VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SONM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SONMDNA X, Inc.
$5.79$73M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSONMFinancials

DNA X, Inc. (SONM) Financials

9Y historyFree accessUpdated daily

Revenue growth has contracted to -100% as of 2026Q1, while gross margins remain highly volatile, fluctuating from a peak of 50% in 2025Q1 to a negative -1.2% in 2024Q4.

SONM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Sales/Revenue-16.72M058.3M93.63M69.83M54.57M63.99M116.25M135.66M59.03M
Revenue Growth %-128.71%-100%-37.74%34.09%27.96%-14.72%-44.95%-14.31%129.82%-
Cost of Goods Sold-4.07M4.3M48.38M74.31M58.2M48.16M48.78M81.74M87.58M38.72M
COGS % of Revenue--82.98%79.36%83.35%88.25%76.23%70.32%64.55%65.59%
Gross Profit-12.66M-4.3M9.92M19.32M11.62M6.41M15.21M34.51M48.09M20.31M
Gross Margin %75.69%-17.02%20.64%16.65%11.75%23.77%29.68%35.45%34.41%
Gross Profit Growth %--143.35%-48.66%66.26%81.21%-57.83%-55.92%-28.24%136.76%-
Operating Expenses-2.99M1.11M43.56M18.81M25.91M44.41M44.47M56.89M42.7M27.08M
OpEx % of Revenue--74.72%20.09%37.11%81.39%69.49%48.94%31.47%45.88%
Selling, General & Admin2.95M5.41M25.35M17.04M17.94M26.72M26.71M30.09M19.45M14.07M
SG&A % of Revenue--43.48%18.2%25.69%48.96%41.73%25.88%14.34%23.84%
Research & Development3.81M014.23M1.77M7.97M17.7M16.22M26.06M23.25M13.01M
R&D % of Revenue--24.42%1.89%11.42%32.43%25.34%22.42%17.14%22.04%
Other Operating Expenses-1000K-4.3M3.98M0001.55M736K00
Operating Income-9.67M-5.41M-33.64M513K-14.29M-38M-29.26M-22.38M5.39M-6.77M
Operating Margin %57.83%--57.7%0.55%-20.46%-69.64%-45.72%-19.25%3.98%-11.47%
Operating Income Growth %-83.93%-6657.31%103.59%62.4%-29.87%-30.74%-514.92%179.68%-
EBITDA-6.42M-1.11M-30.08M2.72M-11.91M-35.87M-26.53M-18.86M7.24M-5.45M
EBITDA Margin %38.42%--51.6%2.9%-17.06%-65.74%-41.46%-16.22%5.34%-9.24%
EBITDA Growth %75.83%96.32%-1206.36%122.82%66.78%-35.2%-40.71%-360.3%232.82%-
D&A (Non-Cash Add-back)3.25M4.3M3.56M2.21M2.38M2.13M2.73M3.52M1.85M1.32M
EBIT-10.77M-6.47M-33.39M299K-13.81M-38.46M-29.69M-22.92M3.86M-7.57M
Net Interest Income-1.53M-1.49M-29K-15K-97K0-759K-1.52M-1.83M-820K
Interest Income0000000000
Interest Expense1.53M-1.49M29K15K97K0759K1.52M1.83M820K
Other Income/Expense-2.8M-2.55M217K-229K387K-459K-1.19M-2.06M-3.36M-1.61M
Pretax Income-12.47M-7.96M-33.42M284K-13.9M-38.46M-30.45M-24.45M2.03M-8.38M
Pretax Margin %74.59%--57.33%0.3%-19.91%-70.48%-47.59%-21.03%1.5%-14.2%
Income Tax-10.4M0226K374K184K167K-521K1.39M754K134K
Effective Tax Rate %83.38%0%-0.68%131.69%-1.32%-0.43%1.71%-5.68%37.12%-1.6%
Net Income-14.78M-20.66M-33.65M-90K-14.09M-38.63M-29.93M-25.83M1.28M-8.52M
Net Margin %88.36%--57.72%-0.1%-20.17%-70.78%-46.77%-22.22%0.94%-14.43%
Net Income Growth %51.21%38.61%-37286.67%99.36%63.53%-29.05%-15.86%-2123.02%114.99%-
Net Income (Continuing)-12.34M-7.96M-33.65M-90K-14.09M-38.63M-29.93M-25.83M1.28M-8.52M
Discontinued Operations1000K-12.7M00000000
Minority Interest0000000000
EPS (Diluted)-1.17-1.59-7.13-0.02-4.88-40.81-64.78-138.87-257.45-1495.71
EPS Growth %-50.04%77.7%-33852.38%99.57%88.04%37%53.35%46.06%82.79%-
EPS (Basic)--28.58-7.13-0.02-4.88-40.81-64.78-138.87-257.45-1495.71
Diluted Shares Outstanding12.65M13.01M4.72M4.29M2.89M946.46K462.09K186.04K34.47K10.27K
Basic Shares Outstanding1.27M722.69K4.72M4.29M2.89M946.46K462.09K186.04K4.96K5.7K
Dividend Payout Ratio----------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Total Revenue Cessation Signals Distress

As indicated by the most recent quarterly financial disclosures, Sonim reported a -100% year-over-year revenue growth rate, suggesting a complete halt in legacy product shipments or a fundamental structural breakdown that renders previous operational models and historical growth trajectories entirely obsolete for current valuation purposes.

The sudden disappearance of top-line revenue in 2026Q1 represents an extreme departure from the already volatile performance observed in prior periods. Investors should interpret this as a potential indicator of a terminal decline in the company's core handset business or a significant accounting shift that warrants immediate scrutiny.

Structural Margin Volatility Remains Unstable

Based on historical income statement data, Sonim's gross margins have exhibited extreme instability, ranging from a peak of 50% in 2025Q1 to a negative -1.2% in 2024Q4, reflecting a lack of pricing power and high sensitivity to carrier-driven inventory adjustments and component cost fluctuations.

The wide variance in gross profitability suggests that the company struggles to maintain consistent unit economics within the competitive ruggedized hardware market. This margin volatility appears to be exacerbated by the company's reliance on third-party manufacturing and the inherent difficulty of managing inventory obsolescence in the Android ecosystem.

Operating Leverage Remains Fundamentally Broken

According to reported financial filings, Sonim has consistently failed to achieve positive operating leverage, with SG&A expenses frequently exceeding gross profit, as evidenced by the -147.5% operating margin recorded in 2024Q4, which highlights a structural inability to scale operations profitably relative to the current revenue base.

The persistent disconnect between operating expenses and gross profit generation suggests that the company's cost structure is misaligned with its actual market demand. Without a significant reduction in fixed overhead or a massive expansion in high-margin software services, the current operating model appears unsustainable.

Liquidity Crisis Threatens Going Concern

As reported in recent financial statements, the company's cash position of approximately $1.3 million, combined with a history of recurring operating losses, suggests a severe liquidity constraint that may force dilutive capital raises or restructuring efforts to maintain operations in the near term.

Short-sellers would likely focus on the company's inability to generate positive cash flow and the high probability of further equity dilution. The lack of revenue in the most recent quarter further complicates the outlook, as the company appears to have exhausted its ability to fund operations through traditional product sales.

SONM — Frequently Asked Questions

Quick answers to the most common questions about buying SONM stock.

What was DNA X, Inc.'s (SONM) revenue in 2025?

For fiscal year 2025, DNA X, Inc. (SONM) reported total revenue of $0.0M. This represents a 100.0% decline compared to $59.0M in 2017.

Is DNA X, Inc. (SONM) profitable?

DNA X, Inc. (SONM) reported a net loss of $20.7M for the fiscal year ending 2025.